More should be done to prevent the harmful effects of long-term androgen ablation therapy in prostate cancer.
Barrass
B J R
BJ
Division of Surgery, University of Bristol, Bristol, UK. barnabybarrass@hotmail.com
Thurairaja
R
R
Persad
R A
RA
D000726:Androgen Antagonists / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal